Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
NCT00401830
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
159
Enrollment
INDUSTRY
Sponsor class
Conditions
Fibromyalgia Syndrome
Interventions
DRUG:
Lacosamide
OTHER:
Placebo
Sponsor
UCB Pharma